Business

Therma Bright Grants Stock Options

Toronto, Ontario--(Newsfile Corp. - June 10, 2022) - Therma Bright Inc. (TSXV: THRM) ("Therma"...

articleTherma Bright Inc.June 10, 20224/company/therma-bright-inc/news/therma-bright-grants-stock-options
Therma Bright Grants Stock Options

About this update from Therma Bright Inc.

[{"type":"text","content":"Therma Bright Grants Stock OptionsToronto, Ontario--(Newsfile Corp. - June 10, 2022) - Therma Bright Inc. (TSXV: THRM) (\"Therma\" or the \"Company\"), developer of the smart-enabled AcuVid™ COVID-19 Rapid Antigen Saliva Test and other progressive medical device technologies, announces that it has granted incentive stock options to certain directors, officers and consultants of the Company to purchase up to an aggregate of 1,475,000 common shares of the Company pursuant to the Company's share option plan. The options are exercisable for a period of three years at a price of $0.25 per share.This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States of America. The securities have not been and will not be registered under the United States Securities Act of 1933 (the \"1933 Act\") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons (as defined in the 1933 Act) unless registered under the 1933 Act and applicable state securities laws, or an exemption from such registration is available.About Therma Bright Inc.Therma Bright, developer of the smart-enabled AcuVid™ COVID-19 Rapid Antigen Saliva Test, is a progressive medical diagnostic and device technology company focused on providing consumers and medical professionals with quality, innovative solutions that address some of today's most important medical and healthcare challenges. The Company's initial breakthrough proprietary technology delivers effective, non-invasive and pain-free skincare. Therma Bright received a Class II medical device status from the FDA for its platform technology that is indicated for the relief of the pain, itch, and inflammation of a variety of insect bites or stings. Therma Bright Inc. trades on the TSXV (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX). Visit: www.thermabright.com. For further information, please contact:Therma Bright Inc.Rob Fia, CEO [email protected] us on TwitterFORWARD LOOKING STATEMENTSCertain statements in this news release constitute \"forward-looking\" statements. These statements relate to future events. All such statements involve substantial known and unknown risks, uncertainties and other factors, which may cause the actual results to vary from those expressed or implied by such forward...

More updates from Therma Bright Inc.